Benoît Lamarche Selected Research

Obesity

1/2023	Associations of insulin-like growth factor binding protein-2 with metabolic profile and hepatic fat deposition in asymptomatic men and women.
1/2022	Polymorphisms in the stearoyl-CoA desaturase gene modify blood glucose response to dietary oils varying in MUFA content in adults with obesity.
2/2007	Association of heterozygous familial hypercholesterolemia with smaller HDL particle size.
12/2006	Endothelial lipase is associated with inflammation in humans.
9/2006	Visceral adiposity and endothelial lipase.
1/2004	Metabolic syndrome and effects of conjugated linoleic acid in obesity and lipoprotein disorders: the Québec experience.
6/2002	Determinants of HDL particle size in patients with the null (P207L) or defective (D9N) mutation in the lipoprotein lipase gene: the Québec LipD Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benoît Lamarche Research Topics

Disease

34	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 06/2003
22	Insulin Resistance 03/2024 - 02/2002
22	Abdominal Obesity 01/2023 - 01/2003
22	Inflammation (Inflammations) 01/2021 - 10/2005
21	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 05/2003
14	Body Weight (Weight, Body) 01/2020 - 08/2003
13	Weight Loss (Weight Reduction) 06/2021 - 10/2003
11	Type 2 Diabetes Mellitus (MODY) 11/2021 - 06/2006
10	Coronary Disease (Coronary Heart Disease) 07/2014 - 02/2002
10	Hypertriglyceridemia 01/2014 - 07/2002
9	Dyslipidemias (Dyslipidemia) 03/2024 - 10/2003
9	Atherosclerosis 01/2018 - 02/2004
8	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 06/2017 - 02/2004
7	Hyperlipidemias (Hyperlipidemia) 03/2024 - 11/2003
7	Obesity 01/2023 - 06/2002
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 06/2004
6	Myocardial Ischemia (Ischemic Heart Diseases) 10/2007 - 02/2002
5	Homozygous Familial Hypercholesterolemia 02/2018 - 08/2016
5	Hypertriglyceridemic Waist 08/2012 - 12/2003
4	Hypertension (High Blood Pressure) 11/2016 - 06/2007
4	Overweight 04/2013 - 08/2005
4	Hyperinsulinism (Hyperinsulinemia) 08/2012 - 06/2006
3	Hypercholesterolemia 08/2012 - 05/2006
2	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2023
2	Prostatic Neoplasms (Prostate Cancer) 07/2019 - 07/2014
2	Atherosclerotic Plaque (Atheroma) 01/2010 - 12/2009
2	Heart Diseases (Heart Disease) 01/2010 - 07/2005
1	Metabolic Diseases (Metabolic Disease) 11/2023
1	Fatty Liver 01/2023
1	Morbid Obesity 06/2021

Drug/Important Bio-Agent (IBA)

37	oxidized low density lipoproteinIBA 03/2024 - 01/2003
33	Triglycerides (Triacylglycerol)IBA 01/2023 - 02/2002
30	Lipoproteins (Lipoprotein)IBA 03/2024 - 02/2002
20	ApolipoproteinsIBA 03/2024 - 10/2003
19	LipidsIBA 01/2021 - 01/2003
15	LDL Lipoproteins (beta Lipoproteins)IBA 03/2024 - 03/2003
15	CholesterolIBA 01/2018 - 01/2004
14	HDL CholesterolIBA 01/2023 - 02/2002
12	Fatty Acids (Saturated Fatty Acids)IBA 03/2024 - 01/2014
11	Insulin (Novolin)FDA Link 01/2021 - 12/2003
10	LDL CholesterolIBA 01/2019 - 05/2003
9	Apolipoprotein B-100 (Apo B 100)IBA 03/2024 - 12/2003
9	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 02/2002
8	Apolipoproteins B (ApoB)IBA 03/2024 - 05/2003
8	Apolipoprotein B-48IBA 06/2017 - 12/2003
6	Monounsaturated Fatty AcidsIBA 03/2024 - 12/2010
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2006
6	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2020 - 07/2014
6	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 07/2013
6	LDL Receptors (LDL Receptor)IBA 01/2017 - 02/2004
6	Interleukin-6 (Interleukin 6)IBA 04/2013 - 10/2005
5	CarbohydratesIBA 09/2018 - 10/2006
5	Corn Oil (Oil, Corn)IBA 01/2018 - 08/2016
5	C-Reactive ProteinIBA 04/2013 - 03/2003
4	Rapeseed OilIBA 01/2019 - 04/2014
4	OilsIBA 01/2018 - 04/2014
4	Oleic Acid (Oleate)IBA 01/2018 - 07/2014
4	Ezetimibe (Zetia)FDA Link 12/2016 - 05/2006
4	Adenosine Triphosphate (ATP)IBA 12/2013 - 08/2009
4	Trans Fatty AcidsIBA 02/2012 - 11/2003
3	AcidsIBA 03/2024 - 07/2014
3	FatsIBA 11/2021 - 06/2009
3	AdiponectinIBA 10/2019 - 08/2008
3	Dextran SulfateIBA 02/2018 - 08/2016
3	Lipoprotein(a)IBA 01/2018 - 03/2002
3	Docosahexaenoic AcidsIBA 08/2016 - 07/2013
3	Eicosapentaenoic AcidIBA 08/2016 - 07/2013
3	Cell Adhesion MoleculesIBA 01/2015 - 03/2008
3	Biomarkers (Surrogate Marker)IBA 11/2014 - 03/2012
3	HDL LipoproteinsIBA 01/2014 - 06/2002
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2013 - 02/2007
3	IsotopesIBA 08/2008 - 05/2006
3	Fenofibrate (CiL)FDA LinkGeneric 03/2008 - 09/2006
3	Lipase (Acid Lipase)FDA Link 06/2007 - 01/2003
2	Insulin-Like Growth Factor Binding Protein 2IBA 01/2023 - 01/2023
2	Insulin-Like PeptidesIBA 01/2023 - 10/2022
2	Unsaturated Dietary FatsIBA 01/2022 - 03/2016
2	PolyphenolsIBA 01/2021 - 01/2018
2	Plant Oils (Vegetable Oils)IBA 01/2018 - 02/2012
2	Safflower Oil FDA Link 01/2018 - 07/2014
2	Nonesterified Fatty Acids (NEFA)IBA 01/2014 - 02/2002
2	CytokinesIBA 07/2013 - 08/2008
2	Tuberculin (PPD)IBA 12/2010 - 01/2006
2	Atorvastatin (Lipitor)FDA Link 03/2008 - 02/2008
2	Fibric Acids (Fibrates)IBA 03/2008 - 02/2008
2	Oxidoreductases (Dehydrogenase)IBA 03/2008 - 02/2008
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 06/2007 - 06/2002
2	Cholesterol Ester Transfer ProteinsIBA 06/2007 - 06/2004
2	Apolipoprotein C-IIIIBA 06/2006 - 10/2005
2	VLDL LipoproteinsIBA 05/2006 - 02/2004
2	Fibrinogen (Factor I)FDA Link 10/2005 - 03/2002
2	Conjugated Linoleic AcidsIBA 08/2005 - 01/2004
1	lardIBA 03/2024
1	Olive OilIBA 03/2024
1	Stearoyl-CoA DesaturaseIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022

Therapy/Procedure

9	Mediterranean Diet 03/2017 - 03/2012
4	Blood Component Removal (Apheresis) 02/2018 - 08/2016
4	Therapeutics 08/2016 - 01/2008
1	Bariatric Surgery 06/2021